To include your compound in the COVID-19 Resource Center, submit it here.

Gemzar gemcitabine: Phase III data

Researchers at the Intergroupe Francophone de Cancerologie Thoracique and colleagues reported data from the open-label, French

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE